JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Wildt, D. J.
Right arrow Articles by Kreeftenberg, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Wildt, D. J.
Right arrow Articles by Kreeftenberg, J. G.

Pharmacological evaluation of purified component and whole-cell pertussis vaccine in the cardiovascular system of rats

DJ de Wildt, Y de Jong, FP Nijkamp and JG Kreeftenberg

The present study compares the cardiovascular activity of a newly introduced and possibly safer acellular pertussis vaccine with that of a conventional whole-cell pertussis vaccine. The vasodilation that occurs after beta-2 adrenoceptor stimulation with salbutamol, as well as the negative chronotropic action induced by the muscarinic receptor stimulant arecoline, were inhibited 4 days after vaccination with two combined diphtheria-pertussis-tetanus whole-cell vaccines and their plain pertussis product. Using doses equivalent to those given to humans, detoxified acellular pertussis component-combined vaccines (diphtheria-pertussis-tetanus) and the nonabsorbed (detoxified pertussis component) induced minimal or no reduction in vascular beta-2 adrenergic and cardiac cholinergic receptor responsiveness as compared to saline-treated animals. Moreover, basal blood pressure values were significantly lower in whole-cell vaccine-treated rats than in animals vaccinated 4 days previously with acellular vaccine (or its ground products). Assuming that the present model can be used to predict the toxicity of pertussis vaccines in infants, it is concluded that the absence of a strong autonomic impairment might point toward the use of a less toxic acellular component vaccine in clinical practice.

Volume 232, Issue 2, pp. 541-544, 02/01/1985
Copyright © 1985 by American Society for Pharmacology and Experimental Therapeutics






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1985 by the American Society for Pharmacology and Experimental Therapeutics.